| Abel Tewodros, MD | |
|
Nw Hospital 1550 North 115th St., Seattle, WA 98133 | |
| (206) 368-1765 | |
| Not Available |
| Full Name | Abel Tewodros |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 29 Years |
| Location | Nw Hospital 1550 North 115th St., Seattle, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396892444 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00036189 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Swedish Issaquah | Issaquah, WA | Hospital |
| Swedish Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastside Emergency Physicians Pllc | 5193725372 | 50 |
News Archive
A University of Arkansas for Medical Sciences research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to kill single cancer cells using the world's smallest laser.
While many bacteria exist as aggressive pathogens, causing diseases ranging from tuberculosis and cholera, to plague, diphtheria and toxic shock syndrome, others play a less malevolent role and some are critical for human health.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that ZEVALIN is now available at hospitals in Hong Kong to patients with indicated non-Hodgkin's lymphoma (NHL), including at Hong Kong Sanatorium & Hospital.
An Australian scientist has been awarded a $1 million research grant to develop innovative gene therapy tools for muscle-related diseases.
Taking omega-3 fatty acids appeared to lower inflammation and guard against further declines in heart function among recent heart attack survivors already receiving optimal standard care, according to results from a randomized, controlled trial to be presented at the American College of Cardiology's 64th Annual Scientific Session in San Diego.
› Verified 6 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831139724 PECOS PAC ID: 9537072814 Enrollment ID: O20031112000189 |
News Archive
A University of Arkansas for Medical Sciences research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to kill single cancer cells using the world's smallest laser.
While many bacteria exist as aggressive pathogens, causing diseases ranging from tuberculosis and cholera, to plague, diphtheria and toxic shock syndrome, others play a less malevolent role and some are critical for human health.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that ZEVALIN is now available at hospitals in Hong Kong to patients with indicated non-Hodgkin's lymphoma (NHL), including at Hong Kong Sanatorium & Hospital.
An Australian scientist has been awarded a $1 million research grant to develop innovative gene therapy tools for muscle-related diseases.
Taking omega-3 fatty acids appeared to lower inflammation and guard against further declines in heart function among recent heart attack survivors already receiving optimal standard care, according to results from a randomized, controlled trial to be presented at the American College of Cardiology's 64th Annual Scientific Session in San Diego.
› Verified 6 days ago
| Entity Name | Eastside Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689683229 PECOS PAC ID: 5193725372 Enrollment ID: O20070111000647 |
News Archive
A University of Arkansas for Medical Sciences research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to kill single cancer cells using the world's smallest laser.
While many bacteria exist as aggressive pathogens, causing diseases ranging from tuberculosis and cholera, to plague, diphtheria and toxic shock syndrome, others play a less malevolent role and some are critical for human health.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that ZEVALIN is now available at hospitals in Hong Kong to patients with indicated non-Hodgkin's lymphoma (NHL), including at Hong Kong Sanatorium & Hospital.
An Australian scientist has been awarded a $1 million research grant to develop innovative gene therapy tools for muscle-related diseases.
Taking omega-3 fatty acids appeared to lower inflammation and guard against further declines in heart function among recent heart attack survivors already receiving optimal standard care, according to results from a randomized, controlled trial to be presented at the American College of Cardiology's 64th Annual Scientific Session in San Diego.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abel Tewodros, MD 7021 27th Ave Ne, Seattle, WA 98115-5843 Ph: (206) 729-6595 | Abel Tewodros, MD Nw Hospital 1550 North 115th St., Seattle, WA 98133 Ph: (206) 368-1765 |
News Archive
A University of Arkansas for Medical Sciences research team led by Vladimir Zharov, Ph.D., D.Sc., has demonstrated the ability to kill single cancer cells using the world's smallest laser.
While many bacteria exist as aggressive pathogens, causing diseases ranging from tuberculosis and cholera, to plague, diphtheria and toxic shock syndrome, others play a less malevolent role and some are critical for human health.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that ZEVALIN is now available at hospitals in Hong Kong to patients with indicated non-Hodgkin's lymphoma (NHL), including at Hong Kong Sanatorium & Hospital.
An Australian scientist has been awarded a $1 million research grant to develop innovative gene therapy tools for muscle-related diseases.
Taking omega-3 fatty acids appeared to lower inflammation and guard against further declines in heart function among recent heart attack survivors already receiving optimal standard care, according to results from a randomized, controlled trial to be presented at the American College of Cardiology's 64th Annual Scientific Session in San Diego.
› Verified 6 days ago
Sasha Kaiser, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Kristopher Allen Hendershot, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Dr. Lauren Kristen Whiteside, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-744-8464 | |
Brenda Park, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-368-5762 Fax: 814-537-5677 | |
Rhadika Mccormick Souza, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 925 Seneca St, Seattle, WA 98101 Phone: 206-583-6433 Fax: 206-583-6583 | |
Eleanor Ganz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-598-4955 | |
Dr. Gary H. Somers, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1550 N 115th St, Seattle, WA 98133 Phone: 206-368-1765 |